Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Yang, G. Zhao, T. Wu, H. Zhou, Y. Ji, Z. Zhang (Shanghai, Dalian, China). Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism. Eur Respir J 2007; 30: Suppl. 51, 3263

Member's Comments

No comment yet.

Related content which might interest you: Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005 Treatment of acute pulmonary embolism Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Treatment of acute pulmonary embolism Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Treatment of acute pulmonary embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Treatment of acute pulmonary embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach Source: Eur Respir J 2015; 45: 1142-1149 Year: 2015 Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021 Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi Source: Eur Respir J, 56 (5) 2000538; 10.1183/13993003.00538-2020 Year: 2020 Short-term mortality in patients with acute symptomatic pulmonary embolism Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism Source: Eur Respir J, 55 (6) 2000189; 10.1183/13993003.00189-2020 Year: 2020 Acute management of pulmonary embolism  Source: International Congress 2017 – Pulmonary emergencies year in review Year: 2017